Search

everythinglearnresearchcommunity

for

Search:↓

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Obese women with PCOS are more likely to have fatty liver disease.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Melanocyte precursors in human fetal skin follow a specific migration pattern and some remain in the skin's deeper layers.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Certain hormone treatments can improve acne and related conditions in women.

Hair loss requires customized treatments based on its various causes and types.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.